Rankings
▼
Calendar
ALXO Q4 2020 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena
ALXO
ALX Oncology Holdings Inc.
$113M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$18M
Net Income
-$19M
EPS (Diluted)
$-0.50
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$436M
Total Liabilities
$6M
Stockholders' Equity
$430M
Cash & Equivalents
$434M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$1M
-100.0%
Gross Profit
$0
$110,000
-100.0%
Operating Income
-$18M
-$8M
-130.5%
Net Income
-$19M
-$8M
-141.8%
← FY 2020
All Quarters
Q1 2021 →